CCRN
Cross Country Healthcare Inc
13.30$
+0.0%
vs. previous close
Closing price · As of: Jul 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.3% | 43.4% | 52.9% | 44.7% | 45.6% | 48.0% | 51.3% | 69.4% | 71.3% | 61.1% | 56.9% | 65.4% | |
| 1.5% | 0.7% | 5.3% | 5.5% | 3.8% | 0.3% | 0.4% | 0.1% | 0.4% | 2.5% | 13.9% | 24.2% | |
| 1.5% | 0.7% | 5.3% | 5.5% | 3.8% | 0.3% | 0.4% | 0.1% | 0.4% | 2.5% | 13.9% | 24.2% | |
| 36.6% | 40.9% | 45.5% | 37.9% | 39.9% | 45.6% | 48.9% | 68.1% | 69.6% | 57.2% | 41.2% | 39.2% | |
| 1.9% | 1.2% | 1.6% | 1.1% | 1.5% | 1.6% | 1.5% | 1.0% | 1.2% | – | – | – | |
| 3.7% | 2.9% | 3.3% | 3.0% | 3.2% | 3.1% | 3.5% | 3.2% | 2.1% | – | – | – | |
| 27.9% | 26.0% | 20.5% | 25.1% | 23.7% | 26.4% | 25.5% | 16.3% | 17.2% | 19.9% | 22.9% | 14.2% | |
| 22.2% | 22.6% | 18.6% | 18.7% | 17.7% | 13.3% | 11.4% | 6.6% | 4.7% | 8.0% | 7.2% | 6.2% | |
| 59.9% | 61.4% | 60.9% | 49.2% | 48.9% | 57.2% | 56.6% | 59.4% | 51.8% | 30.3% | 28.9% | 28.1% | |
| 20.6% | 23.5% | 25.0% | 20.2% | 20.0% | 22.4% | 26.2% | 27.3% | 28.7% | 21.9% | 20.4% | 17.3% | |
| 1.1% | 2.2% | 0.6% | 1.5% | 1.2% | 1.3% | 1.9% | 1.1% | 0.4% | 0.4% | 0.4% | 0.3% | |
| 8.4% | 11.2% | 11.2% | 10.8% | 10.2% | 12.0% | 14.0% | 15.0% | 1.4% | 0.4% | 1.0% | 0.5% | |
| 21.7% | 22.2% | 21.8% | 19.7% | 18.3% | 18.6% | 15.0% | 24.1% | 15.7% | – | – | – | |
| 39.9% | 38.5% | 38.9% | 50.7% | 50.9% | 42.5% | 43.2% | 40.6% | 48.2% | 69.7% | 71.1% | 71.9% | |
| -35.8% | -30.6% | -26.8% | -14.3% | -19.7% | -37.1% | -43.3% | -3.1% | 17.5% | 35.1% | 37.0% | 27.4% | |
| 9.6% | 8.8% | 9.3% | 7.7% | 8.4% | 9.4% | 10.1% | 5.1% | 4.0% | 5.2% | 5.7% | 7.2% |
Data as of: July 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.